These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10369544)

  • 1. Pemphigus in Kuwait.
    Alsaleh QA; Nanda A; Al-Baghli NM; Dvorak R
    Int J Dermatol; 1999 May; 38(5):351-6. PubMed ID: 10369544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
    Kim MR; Kim HC; Kim SC
    Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
    Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
    Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of pemphigus in the western region of Turkey: retrospective analysis of 87 patients.
    Bozdag K; Bilgin İ
    Cutan Ocul Toxicol; 2012 Dec; 31(4):280-5. PubMed ID: 22309241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
    Mahajan VK; Sharma NL; Sharma RC; Garg G
    Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of pemphigus in south-western Iran: a 10-year retrospective study (1991-2000).
    Salmanpour R; Shahkar H; Namazi MR; Rahman-Shenas MR
    Int J Dermatol; 2006 Feb; 45(2):103-5. PubMed ID: 16445496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of pemphigus: a local experience.
    Akhtar SJ; Hasan MU
    J Pak Med Assoc; 1998 Oct; 48(10):300-4. PubMed ID: 10087750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of pemphigus vulgaris.
    Kavusi S; Daneshpazhooh M; Farahani F; Abedini R; Lajevardi V; Chams-Davatchi C
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):580-4. PubMed ID: 18194237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemphigus in Korea: clinical manifestations and treatment protocol.
    Seo PG; Choi WW; Chung JH
    J Dermatol; 2003 Nov; 30(11):782-8. PubMed ID: 14684934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Dapsone in the Treatment of Pemphigus Vulgaris: A Single-Center Case Study.
    Baum S; Debby A; Gilboa S; Trau H; Barzilai A
    Dermatology; 2016; 232(5):578-585. PubMed ID: 27698327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of cyclophosphamide in azathioprine failures in pemphigus.
    Ahmed AR; Hombal S
    J Am Acad Dermatol; 1987 Sep; 17(3):437-42. PubMed ID: 3655023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cases of pemphigus vulgaris and pemphigus foliaceus from a reference service in Pará state, Brazil.
    Pires CA; Viana VB; Araújo FC; Müller SF; Oliveira MS; Carneiro FR
    An Bras Dermatol; 2014; 89(4):556-61. PubMed ID: 25054740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the adjuvant effect of tacrolimus in the management of pemphigus vulgaris: A randomized controlled trial.
    Dastgheib L; Sadati MS; Baghernejhad M
    J Dermatolog Treat; 2015 Feb; 26(1):90-3. PubMed ID: 24552352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pemphigus foliaceus in 91 dogs.
    Mueller RS; Krebs I; Power HT; Fieseler KV
    J Am Anim Hosp Assoc; 2006; 42(3):189-96. PubMed ID: 16611930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of pemphigus vulgaris. Experience with 48 patients seen over an 11-year period.
    Mourellou O; Chaidemenos GC; Koussidou T; Kapetis E
    Br J Dermatol; 1995 Jul; 133(1):83-7. PubMed ID: 7669646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology of pemphigus in the Hospital Universitario Virgen Macarena, Seville, Spain, 2005-2006].
    Coronel-Pérez IM; Rodríguez-Rey EM; Pérez-Bernal AM; Camacho FM
    Actas Dermosifiliogr; 2009 Mar; 100(2):121-5. PubMed ID: 19445876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of a single-center clinical experience toward development of curative treatment of 123 pemphigus patients with a long-term follow-up: efficacy and safety of the multidrug protocol combining intravenous immunoglobulin with the cytotoxic immunosuppressor and mitochondrion-protecting drugs.
    Grando SA
    Int J Dermatol; 2019 Jan; 58(1):114-125. PubMed ID: 30047585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment failure with rituximab in a patient with pemphigus vulgaris.
    Weger W; Aberer E
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):387-9. PubMed ID: 18269618
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic effect of mizoribine on pemphigus vulgaris and pemphigus foliaceus.
    Hashimoto T; Kawakami T; Koga H; Ohyama B; Hamada T; Dainichi T; Nakama T; Yasumoto S; Tsuruta D; Ishii N
    Dermatol Ther; 2012; 25(4):382-5. PubMed ID: 22950566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate is effective in the treatment of pemphigus vulgaris.
    Enk AH; Knop J
    Arch Dermatol; 1999 Jan; 135(1):54-6. PubMed ID: 9923781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.